| Literature DB >> 26579202 |
Cromwell Mwiti Kibiti1, Anthony Jide Afolayan1.
Abstract
<span class="Species">Bulbine abyssinica A. Rich. is used in traditional medicine to treat <span class="Disease">rheumatism, dysentery, bilharzia, cracked lips, back pain, infertility, diabetes mellitus, and gastrointestinal, vaginal, and bladder infections. Therefore, preliminary phytochemical screening, antioxidant, anti-inflammatory, and antibacterial properties of the whole plant (acetone and aqueous extracts) were determined using standard procedures. The in vitro antioxidant model assays revealed that the plant possesses free radical scavenging potential varying with free radical species. The species showed significant protein denaturation inhibitory activity with good protection against erythrocyte membrane lysis indicating anti-inflammatory potential. The results also showed that the species was active against the growth of all the selected eight diabetic status opportunistic bacteria except one. Moreover, the species is characterized by appreciable amounts of total phenols, flavonoids, flavanols, proanthocyanidins, and alkaloids. Traces amounts of saponins and tannins were also observed. Amongst the identified phytochemicals present, empirical searches identified them being antioxidant, anti-inflammatory, and antimicrobial agents. The identification of these phytochemical constituents with their known pharmacological properties indicates that this plant is a good source of the free radical scavenging, anti-inflammatory, and antimicrobial agents. These findings also account for the multipharmacological use of B. abyssinica in fork medicine.Entities:
Year: 2015 PMID: 26579202 PMCID: PMC4633689 DOI: 10.1155/2015/617607
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Phytochemical constituents in the acetone and aqueous extracts of B. abyssinica. Bar graphs with different letter superscript within the same constituent are significantly different (P < 0.05).
Figure 2Reducing power of the acetone and aqueous extracts of Bulbine abyssinica. Line points with different letter superscript within the same concentration are significantly different (P < 0.05).
Scavenging and inflammation inhibitory activities of acetone and aqueous extracts of B. abyssinica.
| Activity | A | B | C | D | E | F | G | H | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Samples | IC50 a |
| IC50 a |
| IC50 a |
| IC50 a |
| IC50 a |
| IC50 a |
| IC50 a |
| IC50 a |
|
| Acetone extract | 1.25 | 78.3 | 0.19 | 79.6 | 0.23 | 89.9 | 0.04 | 88.4 | 0.18 | 83.6 | 0.14 | 86.2 | 0.22 | 74.3 | 0.51 | 90.1 |
| Aqueous extract | 0.19 | 79. 7 | 0.26 | 99.7 | 0.14 | 85.9 | 0.24 | 99.8 | 1.61 | 92.2 | 0.21 | 87.8 | 0.33 | 71.5 | 0.33 | 72.2 |
| BHT | 0.18 | 88.7 | 0.2 | 90.4 | — | — | 0.25 | 99.4 | 2.04 | 84.8 | 0.16 | 87.3 | — | — | — | — |
| Vitamin C | 0.12 | 85.3 | 0.07 | 89.7 | 0.09 | 84.9 | 0.22 | 93.1 | 2.21 | 96.8 | — | — | — | — | — | — |
| Rutin | — | — | 0.26 | 81.4 | 0.23 | 91.1 | — | — | — | — | 0.18 | 81.3 | — | — | — | — |
| Gallic acid | — | — | — | — | — | — | — | — | 1.67 | 76.7 | — | — | — | — | — | — |
| Diclofenac sodium | — | — | — | — | — | — | — | — | — | — | — | — | 0.31 | 91.9 | 0.48 | 81.2 |
A is reducing power; B is DPPH scavenging activity; C is nitric oxide scavenging activity; D is hydrogen peroxide scavenging activity; E is lipid peroxide scavenging activity; F is ABTS scavenging activity; G is protein denaturation inhibitory activity; and H is membrane lysis inhibitory activity. aIC50 is defined as the concentration (mg/mL) sufficient to obtain 50% of a maximum scavenging capacity. bCoefficient of determination. Values are obtained from regression lines with 95% confidence level. — indicates values not determined.
Figure 3DPPH radical scavenging activity of the acetone and aqueous extracts of B. abyssinica. Bar graphs with different letter superscript within the same concentration are significantly different (P < 0.05).
Figure 4Nitric oxide radical scavenging activity of the acetone and aqueous extracts of B. abyssinica. Bar graphs with different letter superscript within the same concentration are significantly different (P < 0.05).
Figure 5Lipid peroxidation scavenging activity of the acetone and aqueous extracts of B. abyssinica. Bar graphs with different letter superscript within the same concentration are significantly different (P < 0.05).
Figure 6Hydrogen peroxide radical scavenging activity of the acetone and aqueous extracts of B. abyssinica. Line points with different letter superscript within the same concentration are significantly different (P < 0.05).
Figure 7ABTS radical scavenging activity of the acetone and aqueous extracts of B. abyssinica. Bar graphs with different letter superscript within the same concentration are significantly different (P < 0.05).
Protein denaturation activity of acetone and aqueous extracts of B. abyssinica.
| Concentration ( | Standard (diclofenac sodium) | Acetone extract of | Aqueous extract of |
|---|---|---|---|
| Mean % inhibition ± SD | Mean % inhibition ± SD | Mean % inhibition ± SD | |
| 500 | 98.68 ± 2.28a | 85.09 ± 0.76b | 67.98 ± 11.50c |
| 400 | 95.61 ± 0.76a | 79.39 ± 0.75b | 78.95 ± 2.63b |
| 300 | 87.72 ± 1.52a | 72.81 ± 5.93a | 85.09 ± 21.43a |
| 200 | 88.16 ± 2.01a | 71.06 ± 2.28b | 93.86 ± 2.01a |
| 100 | 83.77 ± 0.76a | 30.70 ± 5.32b | 86.40 ± 0.76a |
Data expressed as means ± SD; n = 3; values along a row with different superscripts are significantly different (P < 0.05).
Effect of acetone and aqueous extracts of B. abyssinica on erythrocyte membrane haemolysis.
| Concentration ( | Standard (diclofenac sodium) | Acetone extract of | Aqueous extract of |
|---|---|---|---|
| Mean % inhibition ± SD | Mean % inhibition ± SD | Mean % inhibition ± SD | |
| 1000 | 89.19 ± 1.78a | 70.72 ± 0.77b | 79.50 ± 1.41c |
| 500 | 79.95 ± 6.14a | 56.31 ± 0.78b | 75 ± 1.17a |
| 400 | 79.51 ± 2.17a | 34.69 ± 0.79b | 62.61 ± 2.17c |
| 300 | 63.06 ± 2.81a | 30.63 ± 0.39b | 44.14 ± 0.78c |
| 200 | 58.56 ± 1.03a | 31.08 ± 0.68b | 41.89 ± 1.35c |
| 100 | 58.55 ± 0.78a | 21.4 ± 0.78b | 16.44 ± 0.39c |
Data expressed as means ± SD; n = 3; values along a row with different superscripts are significantly different (P < 0.05).
Inhibition zone diameters caused by acetone and aqueous extracts of B. abyssinica (50 mg/mL) against the tested opportunistic bacteria.
| Sample | Inhibition zone diameter (mm) | |||||||
|---|---|---|---|---|---|---|---|---|
| Sf | Pa | Sa | Ef | Kp | Sp | Pv | Sm | |
| Acetone extract | 23.33 ± 3.061 a | 20 ± 3.461 a | 35 ± 2.652 a | 24 ± 3.461 a | 14.67 ± 0.583 a | 14.33 ± 1.533 a | 20.33 ± 0.581 a | 0 |
| Aqueous extract | 17.67 ± 6.031 a | 12 ± 1.731 b | 41 ± 3.462 b | 14.67 ± 6.351 b | 16 ± 1.731 a | 16.67 ± 2.081 a | 18.67 ± 1.151 a | 0 |
| Control | 22.67 ± 2.311 a | 27 ± 3.461 c | 30.67 ± 3.512 c | 26.67 ± 3.791 a | 23.67 ± 0.581 b | 38.33 ± 1.533 b | 41.67 ± 2.894 b | 32.56 ± 2.442 |
The bacteria isolates are denoted as Sf (Shigella flexneri), Pa (Pseudomonas aeruginosa), Sa (Staphylococcus aureus), Ef (Enterococcus faecalis), Kp (Klebsiella pneumonia), Sp (Streptococcus pyogenes), Pv (Proteus vulgaris), and Sm (Serratia marcescens). Data expressed as means ± SD; n = 3; values along a row with different subscripts are significantly different (P < 0.05). Mean with the different superscript in the same column is significantly different (P < 0.05). Concentration of positive control is 0.013 mg/mL.
Minimum inhibitory concentrations (MIC) of acetone and aqueous extracts of B. abyssinica against the tested opportunistic bacteria.
| Sample | MIC (mg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|
| Sf | Pa | Sa | Ef | Kp | Sp | Pv | Sm | |
| Acetone extract | 0.631 a | 0.312 a | 0.312 a | 0.312 a | 2.53 a | >54 a | 1.255 a | — |
| Aqueous extract | 0.311 b | >52 b | 0.0783 b | 1.254 b | 2.55 a | 52 a | 0.636 b | — |
| Control | 0.161 c | 0.161 c | 0.161 c | 0.161 c | 0.161 b | 0.161 b | 1.252 a | 0.161 |
The bacteria isolates are denoted as Sf (Shigella flexneri), Pa (Pseudomonas aeruginosa), Sa (Staphylococcus aureus), Ef (Enterococcus faecalis), Kp (Klebsiella pneumonia), Sp (Streptococcus pyogenes), Pv (Proteus vulgaris), and Sm (Serratia marcescens). “—” denotes values not determined. Data expressed as means ± SD; n = 3; values along a row with different subscripts are significantly different (P < 0.05). Mean with the different superscript in the same column is significantly different (P < 0.05). Concentration of positive control is 0.013 mg/mL.